ARC
AMRI

Absolute Return Capital’s Albany Molecular Research Inc AMRI Stock Holding History

Absolute Return Capital’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20,218
Closed -$407K – 1127
2014
Q2 		$407K Buy
20,218
+5,995
+42% +$102K ﹤0.01% 883
2014
Q1 		$264K Buy
+14,223
New +$196K ﹤0.01% 993

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Absolute Return Capital's AMRI Position: Q3 2014 in Review

Absolute Return Capital sold out of Albany Molecular Research Inc (AMRI) in Q3 2014, closing a stake of 20,218 shares — an estimated $407K sold.

Absolute Return Capital first reported a position in AMRI in Q1 2014 and held it in 2 quarters. The position peaked at $407K in Q2 2014. 143 funds tracked by Wall St. Rank hold AMRI as of Q3 2014.

  • Absolute Return Capital reported no remaining Albany Molecular Research Inc position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 20,218 Albany Molecular Research Inc shares in Q3 2014, an estimated $407K.
  • Absolute Return Capital first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 2 quarters.
  • Absolute Return Capital's Albany Molecular Research Inc position peaked at $407K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.